US OptionsDetailed Quotes
AUR241220C2000
- 4.80
- 0.000.00%
15min DelayTrading Oct 29 09:30 ET
0.00High0.00Low
0.00Open4.80Pre Close0 Volume2 Open Interest2.00Strike Price0.00Turnover209.81%IV10.21%PremiumDec 20, 2024Expiry Date4.17Intrinsic Value100Multiplier32DDays to Expiry0.63Extrinsic Value100Contract SizeAmericanOptions Type0.9843Delta0.0101Gamma1.47Leverage Ratio-0.0026Theta0.0016Rho1.45Eff Leverage0.0007Vega
Aurora Innovation Stock Discussion
Once this sell-off is done, time to jump back in.
The delay in launch (as stated in earnings call) was due to factors outside their control. Paccar supply issues prevented the timeline for regulations and testing being met.
To see why this isn't a bad thing, refer to "contra R&D expense"
Some assistance for the unfamiliar:
$Monopar Therapeutics (MNPR.US)$
$Aurora Innovation (AUR.US)$
and $Grindr (GRND.US)$
are also boosting portfolios….
and
and
and
are also doing ok (beyond the obvious $Tesla (TSLA.US)$ , $NVIDIA (NVDA.US)$ and $MicroStrategy (MSTR.US)$ .
as a high reward with decreasing risks play, for short term trades, and, if they show that they can scale, a longterm hold.
It is part of my speculation basket that includes companies like $AST SpaceMobile (ASTS.US)$
and $Aurora Innovation (AUR.US)$
all of which I trade in shorterm options, trade and invest in longer dated contracts and warrants, and invest in shares, LEAPS calls and synthetic longs.
I’ve traded out of December AUR cal...
loading...
$Concentration$
$Concentration$
$Speculation$
Obviously not a long time frame. Handily beats depending on risk definition. This is buy and hold high risk but less and kess risky to my estimates.
No comment yet